BPC-157 + TB-500 Research Blend
A combined-pathway research blend: BPC-157 5 mg and TB-500 5 mg in a single vial. The two compounds act through different mechanisms — growth-factor and angiogenesis signalling for BPC-157, actin-sequestration and cell-migration regulation for TB-500 — and are paired by researchers studying simultaneous tissue-recovery pathways.
Why researchers pair the two compounds
BPC-157 and TB-500 occupy different parts of the tissue-recovery research literature. BPC-157 is associated with growth-factor expression, new blood-vessel formation (angiogenesis), and nitric-oxide-pathway signalling. TB-500 is associated with actin-cytoskeleton regulation and cell migration. The two pathways are largely independent — there is no published evidence of pharmacological interaction between the molecules. Researchers studying composite recovery questions (where multiple tissue-remodelling pathways are in play simultaneously) use the blend to address both axes in one administration.
How the blend is formulated
Each vial contains 5 mg BPC-157 and 5 mg TB-500 as lyophilised powder, manufactured upstream under ICH Q7 GMP and verified by independent HPLC at a US-based third-party laboratory. Both peptides are confirmed individually to ≥98% peak-area purity against pharmacopoeia reference standards (USP-NF, Ph. Eur., JP) before being co-formulated. The Certificate of Analysis covers both compounds independently and confirms the combined vial composition.
When to use the blend vs the two compounds separately
Researchers studying single-mechanism questions choose one compound at a time and run separate cycles. Researchers studying composite or paired-pathway questions choose the blend for two reasons: one administration handles both compounds (practical efficiency), and the published grey-research community has accumulated more protocol experience with the paired approach than with either alone. The pairing is the most-cited combination in tissue-recovery research forums.
Quality verification
Two-stage verification per the Wellness Labs framework: upstream ICH Q7 Good Manufacturing Practice, independent HPLC analysis at a third-party US laboratory. Acceptance criterion: ≥98% peak-area purity at λ=214 nm for each constituent compound. Method specifications and reference standards are published on our quality page; batch-specific chromatograms are available on request through the research account.
In the bpc + tb-500 blend range
Common questions
- Is the BPC + TB-500 blend legal in the UAE?
- Both constituent compounds are classified as research compounds in the UAE and are sold through standard wellness-supply channels. The combined blend follows the same classification. Wellness Labs operates under standard UAE commercial trading rules with VAT compliance applied to every dispatch.
- Does the blend interact with itself — does BPC-157 affect TB-500?
- No published evidence indicates pharmacological interaction between the two molecules. They act through largely independent pathways: BPC-157 via growth-factor and nitric-oxide-pathway signalling, TB-500 via actin-sequestration. Researchers studying the blend report no compounded tolerability issues at standard research doses.
- How is the blend typically dosed?
- Protocols vary widely in the grey-research community. The most-commonly-cited approach is treating the blend as both compounds dosed simultaneously at their individual research-protocol levels — typically a loading phase of 4-6 weeks at higher frequency, followed by a maintenance or rest phase. Specific dosing decisions sit with the researcher; Nour walks through the literature during a consultation.
- What is the cost per vial vs buying both compounds separately?
- The blend is priced below the sum of the two standalone vials — a per-compound discount for the paired format. Talk to Nour for current pricing in your delivery region; AED pricing applies inside the UAE.
- How do I reconstitute the blend?
- Reconstitution protocol details accompany every shipment. Standard practice: bacteriostatic water for injection, gentle swirling (do not shake vigorously — peptide molecules are mechanically sensitive), refrigerated post-reconstitution storage. Volume and dilution depend on the per-dose target; the included protocol sheet covers the calculations.
- How fast is delivery in the UAE?
- Same-day in Dubai, next-business-day across the UAE. GCC (Saudi Arabia, Kuwait, Bahrain, Oman, Qatar) in 3-5 business days. Cold-chain handling is applied where the protocol requires it.
- Can Nour help me decide between the blend and the standalone compounds?
- Yes. Nour walks through the difference between paired-pathway research and single-mechanism research, what the literature shows for each, and which approach fits your protocol. Available in English and Arabic.
Related categories
Not sure which is right for you?
Nour reads peer-reviewed studies and walks you through what each compound is best suited for. English or Arabic, inside the chat.